Supraventriküler Taşikardiye Bağlı Non-İmmun Hidrops Fetalis

Yıl 2020, Cilt: 1 Sayı: 1, 24 - 27, 01.01.2020

Lale Guliyeva Ramazan Özdemir İsmail Kürşad Gökçe

Öz

Hidrops fetalis immun hidrops fetalis ve non-immun hidrops fetalis olarak iki temel grupta sınıflandırılır. Non-immun hidrops fetalis etiyolojisinde kardiyak yapısal malformasyonlar ve kardiyak aritmiler en sık (%20-25) nedenlerdendir. Fetal taşikardi iyi bilinen bir non-immunhidrops nedenidir.En sık bildirilen fetal taşikardi ise supraventriküler taşikardi (SVT) olup tüm fetal taşikardilerin %70-80’ni oluşturmaktadır. Biz bu makalede digoksin ve esmolol kombine tedavisi uygulayıp başarılı olduğumuz bir SVT’ye bağlı hidrops fetalisli yenidoğan olgusunu sunup literatürdeki tedavi protokollerini gözden geçirmek istedik.

Anahtar Kelimeler

Digoksin, Esmolol, Hidrops fetalis, Yenidoğan supraventriküler taşikardi

Non-Immune Hydrops Fetalis Case Due To Supraventricular Tachycardia

Öz

Hydrops fetalis is classified in two main groups as immune hydrops fetalis and non-immune hydrops fetalis. Cardiac structural malformations and cardiac arrhythmias are the most common (%20-25) causes of non-immune hydrops fetalis etiology. Fetal tachycardia is a well-known cause of non-immune hydrops. The most frequently reported fetal tachycardia is supraventricular tachycardia, which is 70-80% of all fetal tachycardias. We presented a neonatal case of SVT induced hydrops fetalis with digoxin and esmolol combined treatment and reviewed the treatment protocols in the literature.

Anahtar Kelimeler

Digoxin, Esmolol, Hydrops fetalis, Neonatal supraventricular tachycardia

Kaynakça

• 1. Bellini C, Hennekam RCM, Fulcheri E, et al. Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet 2009; 149: 844-51.
• 2. Oudijk MA, Visser GH, Meijboom EJ. Fetal Tachyarrhythmia – Part 1: Diagnosis. Indian Pacing Electrophysiol J 2004; 4: 104
• 3. Norton ME. Nonimmune hydrops fetalis. Semin Perinatol 1994; 18: 321–332.
• 4. Ayida GA, Soothil PW, Rodeck CH. Survival in non-immune hydropsfetalis without malformation of chromosomal abnormalities after invasive treatment. Fetal Diagn Ther 1995; 10: 101–105
• 5. Moak JP. Supraventricular tachycardia in the neonate and infant. Prog Pediatr Cardiol 2000; 11: 25-38.
• 6. Lewis L, Poojari G, Sanoj KM, Kamath SP, Kachane YP. Neonatal arrhythmia with diaphragmatic eventration. Indian J Pediatr 2008; 75: 1083-5.
• 7. De Giovanni JV, Dindar A, Griffith MJ, et al. Recovery pattern of left ventricular dysfunction following radiofrequency ablation of incessant supraventricular tachycardia in infants and children. Heart 1998; 79: 588-92.
• 8. Murphy JH. Nonimmune hydrops fetalis. Neo Reviews 2004; 5: 5-14.
• 9. Hrtánková M, Biringer K, Siváková J, Šumichrastová P, Lukáč P, Danko J. Fetal magnetocardiography: a promising way to diagnose fetal arrhytmia and to study fetal heart rate variability? Ceska Gynekol 2015; 80: 58-63.
• 10. Kothari DS, Skinner JR. Neonatal tachycardias: an update. Arch Dis Child Fetal Neonatal Ed 2006; 91: 136-44.
• 11. Cuneo BF, Strasburger JF. Management strategy for fetal tachycardia. Obstet Gynecol 2000; 96: 575-81.
• 12. Van Hare GF. Neonatal arrhythmias. In: Fanaroff AA, Martin RJ (eds). Neonatal Perinatal Medicine Diseases of the Fetus and Infant (7th ed). St. Louis: Mosby, 2002: 1150- 63.
• 13. Oudijk MA, Visser GH, Meijboom EJ. Fetal tachyarrhythmia - Part 1Fetal Tachyarrhythmia - Part II: Treatment. Electrophysiol J 2004; 4: 185-94.
• 14. Merriman JB, Gonzalez JM, Rychik J. Can digoxin and sotalol therapy for fetal supraventricular tachycardia and hydrops be successful? A case report. J Reprod Med 2008; 53: 357-9.
• 15. Akdeniz C, Kıplapınar M, Şengül FS, Tuzcu V. Antiaritmik tedaviye cevapsız supraventriküler taşikardili yenidoğanda katater ablasyonu ile tedavi. Anadolu Kardiyoloji Dergisi 2012; 12: 1-3.
• 16. Ceviz N, Çeliker A. Çocuklarda görülen aritmilerin farmakolojik tedavisi. Türk Aritmi Pacemaker ve Elektrofizyoloji Dergisi 2005; 3: 173-87.
• 17. Etches P, Demianczuk N, Chari R. Nonimmune hydropsfetalis. In: Rennie JM, editor. Roberton’s Textbook of Neonatology. 4th ed. Philadelphia: Elsevier Churchill Livingstone. 2005: 773-84.